Indication
Lobular Carcinoma In Situ
7 clinical trials
6 products
1 drug
Clinical trial
Phase I Trial of Endoxifen Gel Versus Placebo Gel in Women Undergoing Breast SurgeryStatus: Active (not recruiting), Estimated PCD: 2021-02-22
Product
EndoxifenClinical trial
Refining Tamoxifen Dose for Premenopausal Breast Cancer Risk Reduction (RENAISSANCE): A Phase II Single Arm TrialStatus: Not yet recruiting, Estimated PCD: 2027-12-31
Drug
TamoxifenClinical trial
Phase IIA Trial of Acolbifene (20 mg) vs Low Dose Tamoxifen (5 mg) in Pre-Menopausal Women at High Risk for Development of Breast CancerStatus: Not yet recruiting, Estimated PCD: 2026-09-01
Product
AcolbifeneClinical trial
Testing for Atypia in Random Periareolar Fine Needle Aspiration (RPFNA) Cytology After 12 Months Metformin (1, 1-Dimethylbiguanide Hydrochloride) Chemoprevention Versus Placebo Control in Premenopausal WomenStatus: Active (not recruiting), Estimated PCD: 2023-11-10
Product
MetforminClinical trial
Window Trial of Abemaciclib for Surgically Resectable, Chemotherapy-Resistant, Triple Negative Breast Cancer (a BEAUTY Study*)Status: Recruiting, Estimated PCD: 2024-07-31
Product
AbemaciclibClinical trial
Phase 2 Study of Low Dose Tamoxifen +/- High Dose Omega-3 Fatty Acids in Overweight Postmenopausal Women at Increased Risk for Breast CancerStatus: Not yet recruiting, Estimated PCD: 2027-01-01
Product
Omega-3-Acid Ethyl EstersClinical trial
Intra-mammary Distribution of Transdermal Telapristone Versus Oral Telapristone: A Randomized Window Trial in Women Undergoing MastectomyStatus: Completed, Estimated PCD: 2018-01-01
Product
Telapristone